Skip to news
JQJO
Latest

Could This Spray Stop Your COVID-19 Risk? | JQJO

Could This Spray Stop Your COVID-19 Risk?

Could This Spray Stop Your COVID-19 Risk?

Tap title to read story

0:00 / 0:40

A German study suggests that a daily nasal spray containing azelastine, a common allergy medication, may significantly reduce COVID-19 infection rates. In a trial involving 450 adults, those using the spray experienced a 67% lower infection rate compared to a placebo group. While the sample size was relatively small, the results also indicated a slower infection onset and shorter positive test duration in the azelastine group. The spray also seemed to reduce other respiratory infections. Larger studies are needed to confirm these promising findings.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Man Utd Tchouameni Move Fails

Tap title to read story

0:00 / 0:42

Angelina Jolie Thriller Exits Netflix

Tap title to read story

0:00 / 0:42

Tornado Warning Issued for MD2459

Tap title to read story

0:00 / 0:46

Ukrainian Nuclear Plant Cuts Output

Tap title to read story

0:00 / 0:45

JQJO

Find your next story

Search JQJO’s current coverage.